GSI (GSIT) Q3 2026 earnings summary

Executive summary

• Q3 fiscal 2026 revenue increased 12.2% year-over-year to $6.1 million, with nine-month revenue up 28.5% to $18.8 million, driven by higher average selling prices, unit volumes, and strong demand for SRAM and new products.

• Net loss for the quarter was $3.0 million ($0.09 per share), improved from $4.0 million ($0.16 per share) a year ago, with operating loss at $6.9 million due to increased R&D investment, especially for associative computing and the Plato project.

• Cash and cash equivalents surged to $70.7 million as of December 31, 2025, mainly from a $46.9 million registered direct offering and additional equity raises, with no debt outstanding.

• Achieved milestones for Gemini-II, including third-party benchmark validation, a three-second TTFT, and government proof-of-concept agreements.

• Finalized partnership with G2 Tech for the Sentinel project, securing over $1 million in government funding.

Financial highlights

• Net revenues for Q3 fiscal 2026 were $6.1 million, up from $5.4 million in Q3 fiscal 2025, but down from $6.4 million in Q2 fiscal 2026.

• Gross margin was 52.7% for the quarter, compared to 54% a year ago and 54.8% in the prior quarter, with margin improvement for the nine months attributed to product mix and reduced severance costs.

• Operating expenses rose to $10.1 million, with R&D at $7.5 million and SG&A at $2.6 million, mainly due to IP purchases and consulting.

• Net loss was $3.0 million (9 cents per diluted share), compared to $4.0 million (16 cents) a year ago and $3.2 million (11 cents) in the prior quarter.

• Q3 included a non-cash accounting adjustment of $6.2 million for pre-funded warrants and $2.8 million in issuance costs from a recent offering.

Outlook and guidance

• Q4 fiscal 2026 net revenues expected between $5.7 million and $6.5 million, with gross margin projected at 54%–56%.

• Management expects continued negative impact from inflation, tariffs, trade barriers, and geopolitical tensions through fiscal 2026 and into 2027.

• The company believes its cash position is sufficient for at least the next 12 months, but future capital needs depend on revenue growth, cost trends, and product development.

• Continued focus on government and strategic partner funding to support R&D and commercialization.